Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | NNMT |
| Upstream (Parents) |
|---|
| (<<) CASP4 → NNMT |
| (<<) CAV1 → NNMT |
| (<<) CLEC2B → NNMT |
| (<<) GPNMB → NNMT |
| (<<) HOPX → NNMT |
| (<<) IGFBP7 → NNMT |
| (<<) MYL9 → NNMT |
| (<<) RECK → NNMT |
| (<<) RPS16 → NNMT |
| (<<) SH3GLB1 → NNMT |
| (<<) VIM → NNMT |
| Downstream (Children) |
|---|
| NNMT → ADAM12 (>>) |
| NNMT → ADAM9 (>>) |
| NNMT → AKT3 (>>) |
| NNMT → ANXA2 (>>) |
| NNMT → ARL4C (>>) |
| NNMT → ATP2B4 (>>) |
| NNMT → BCL2L13 (>>) |
| NNMT → BRCA1 (>>) |
| NNMT → CCND2 (>>) |
| NNMT → CDC42EP1 (>>) |
| NNMT → CDH11 (>>) |
| NNMT → CDKN1A (>>) |
| NNMT → CDKN2A (>>) |
| NNMT → CHI3L1 (>>) |
| NNMT → COTL1 (>>) |
| NNMT → CRYAB (>>) |
| NNMT → CTGF (>>) |
| NNMT → CXCL2 (>>) |
| NNMT → CYR61 (>>) |
| NNMT → DPH2 (>>) |
| NNMT → EGFR (>>) |
| NNMT → EMP1 (>>) |
| NNMT → FNDC4 (>>) |
| NNMT → FZD7 (>>) |
| NNMT → GPX7 (>>) |
| NNMT → GULP1 (>>) |
| NNMT → HCN4 (>>) |
| NNMT → HIF1A (>>) |
| NNMT → ICAM2 (>>) |
| NNMT → ID1 (>>) |
| NNMT → ISLR (>>) |
| NNMT → KCTD12 (>>) |
| NNMT → LGALS3 (>>) |
| NNMT → LIF (>>) |
| NNMT → MEGF6 (>>) |
| NNMT → MMP19 (>>) |
| NNMT → MMP2 (>>) |
| NNMT → MYLK (>>) |
| NNMT → NBL1 (>>) |
| NNMT → PLCB4 (>>) |
| NNMT → PLEKHF1 (>>) |
| NNMT → PTRF (>>) |
| NNMT → RRAS (>>) |
| NNMT → SEPW1 (>>) |
| NNMT → STEAP1 (>>) |
| NNMT → STX1A (>>) |
| NNMT → SULT2B1 (>>) |
| NNMT → SYNPO (>>) |
| NNMT → THY1 (>>) |
| NNMT → TNC (>>) |
| NNMT → UBE2E3 (>>) |
| NNMT → UPP1 (>>) |
